Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Maintains Overweight on Hologic, Raises Price Target to $95

JP Morgan analyst Casey Woodring maintains Hologic (NASDAQ:HOLX) with a Overweight and raises the price target from $90 to $95.
byBenzinga Newsdesk
February 2, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

JP Morgan analyst Casey Woodring maintains Hologic (NASDAQ:HOLX) with a Overweight and raises the price target from $90 to $95.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0